DTIL
Precision BioSciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$186.55M
P/E Ratio
—
EPS
$-2.17
Beta
1.31
52W High
$8.82
52W Low
$3.53
50-Day MA
$6.96
200-Day MA
$5.48
Dividend Yield
—
Profit Margin
-96.70%
Forward P/E
11.78
PEG Ratio
—
About Precision BioSciences Inc
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
Fundamentals
| Revenue (TTM) | $45.07M |
| Gross Profit (TTM) | $45.07M |
| EBITDA | $-37.74M |
| Operating Margin | -83.70% |
| Return on Equity | -70.90% |
| Return on Assets | -18.20% |
| Revenue/Share (TTM) | $2.71 |
| Book Value | $3.83 |
| Price-to-Book | 2.39 |
| Price-to-Sales (TTM) | 4.14 |
| EV/Revenue | 2.028 |
| EV/EBITDA | -0.27 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 37272.00% |
| Shares Outstanding | $25.80M |
| Float | $20.01M |
| % Insiders | 6.44% |
| % Institutions | 65.58% |
Historical Volatility
HV 10-Day
72.19%
HV 20-Day
57.69%
HV 30-Day
64.92%
HV 60-Day
79.70%
HV Rank
61.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($32.00 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026